neuroendocrine carcinoma การใช้

GPR112 gene expression has been identified as a marker for neuroendocrine carcinoma cells.
The more aggressive endocrine pancreatic cancers are known as pancreatic neuroendocrine carcinomas ( PNEC ).
Low-to intermediate-grade neuroendocrine carcinomas of the pancreas may be called islet cell tumors.
In its early stages, neuroendocrine carcinoma is asymptomatic ( not showing or producing indications of a disease or other medical condition ).
One clinically significant subtype is " large-cell neuroendocrine carcinoma " ( LCNEC ), which is believed to derive from neuroendocrine cells.